Multipotent mesenchymal stromal cells (MSC) are the key regulators of hematopoiesis. We studied changes in MSC characteristics in patients with myeloid leukemia and patients with lymphoproliferative diseases. MSC were obtained from the bone marrow of patients at the time of diagnostic puncture using a standard technique. Their proliferative potential and expression of genes associated with differentiation and regulation of hematopoiesis were studied. The total cell production of MSC in patients with leukemia at the onset of the disease did not differ from that in the group of healthy donors. The relative expression of the IL6, TGFb1 and TGFb2, PPARG genes was similar in all patients. The relative expression of the JAG1, LIF, IGF1, CSF1, IL1b, and IL1bR1 genes in MSC of patients with leukemia was enhanced and the relative expression of SDF1 was unchanged in comparison with MSC from donors. MSC from patients with leukemia were characterized by enhanced relative expression of PDGFRA and PDGFRB, and reduced expression of SOX9. Changes functions of the stromal microenvironment in patients with hemoblastoses attested to the role of stromal cells in the maintenance and spread of tumor cells.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Romanov YuA, Chervontseva AM, Savchenko VG. Damage to vascular endothelium in the treatment of acute leukemia: in vitro study. Ter. Arkh. 2004;76(7):34-40. Russian.
Azadniv M, Myers JR, McMurray HR, Guo N, Rock P, Coppage ML, Ashton J, Becker MW, Calvi LM, Liesveld JL. Bone marrow mesenchymal stromal cells from acute myelogenous leukemia patients demonstrate adipogenic differentiation propensity with implications for leukemia cell support. Leukemia. 2020;34(2):391-403. doi: https://doi.org/10.1038/s41375-019-0568-8
Di Raimondo F, Palumbo GA, Azzaro MP, Giustolisi R. Angiogenesis in acute myeloid leukemia. Blood. 2000;96(10):3656-3657.
Fastova EA, Magomedova AU, Petinati NA, Sats NV, Kapranov NM, Davydova YO, Drize NI, Kravchenko SK, Savchenko VG. Bone marrow multipotent mesenchymal stromal cells in patients with diffuse large B-cell lymphoma. Bull. Exp. Biol. Med. 2019;167(1):150-153. doi: https://doi.org/10.1007/s10517-019-04480-6
Gnecchi M, Zhang Z, Ni A, Dzau VJ. Paracrine mechanisms in adult stem cell signaling and therapy. Circ. Res. 2008;103(11):1204-1219. doi: https://doi.org/10.1161/CIRCRESAHA.108.176826
Kuznetsov SA, Mankani MH, Bianco P, Robey PG. Enumeration of the colony-forming units-fibroblast from mouse and human bone marrow in normal and pathological conditions. Stem Cell Res. 2009;2(1):83-94. doi: https://doi.org/10.1016/j.scr.2008.07.007
Lee MW, Ryu S, Kim DS, Lee JW, Sung KW, Koo HH, Yoo KH. Mesenchymal stem cells in suppression or progression of hematologic malignancy: current status and challenges. Leukemia. 2019;33(3):597-611. doi: https://doi.org/10.1038/s41375-018-0373-9
Morrison SJ, Scadden DT. The bone marrow niche for haematopoietic stem cells. Nature. 2014;505:327-334. doi: https://doi.org/10.1038/nature12984
Nifontova IN, Svinareva DA, Drize NJ. Stromal clonogenic precursors of hemopoietic microenvironment and their rank in the hierarchy of mesenchymal stem cells. Bull. Exp. Biol. Med. 2008;145(4):544-547. doi: https://doi.org/10.1007/s10517-008-0137-z
Petinati NA, Bigildeev AE, Karpenko DS, Sats NV, Kapranov NM, Davydova YO, Fastova EA, Magomedova AU, Kravchenko SK, Arapidi GP, Rusanova MI, Lagarkova MM, Drize NI, Savchenko VG. Humoral effect of a B-cell tumor on the bone marrow multipotent mesenchymal stromal cells. Biochemistry (Mosc). 2021;86(2):207-216. doi: https://doi.org/10.1134/S0006297921020097
Schmittgen TD, Livak KJ. Analyzing real-time PCR data by the comparative CT method. Nat. Protoc. 2008;3(6):1101-1108. doi: https://doi.org/10.1038/nprot.2008.73
Schroeder T, Geyh S, Germing U, Haas R. Mesenchymal stromal cells in myeloid malignancies. Blood Res. 2016;51(4):225-232. doi: https://doi.org/10.5045/br.2016.51.4.225
Sharma M, Ross C, Srivastava S. Ally to adversary: Mesenchymal stem cells and their transformation in leukaemia. Cancer Cell Int. 2019;19:139. doi: https://doi.org/10.1186/s12935-019-0855-5
Tiong KH, Mah LY, Leong CO. Functional roles of fibroblast growth factor receptors (FGFRs) signaling in human cancers. Apoptosis. 2013;18(12):1447-1468. doi: https://doi.org/10.1007/s10495-013-0886-7
Yehudai-Resheff S, Attias-Turgeman S, Sabbah R, Gabay T, Musallam R, Fridman-Dror A, Zuckerman T. Abnormal morphological and functional nature of bone marrow stromal cells provides preferential support for survival of acute myeloid leukemia cells. Int. J. Cancer. 2019;144(9):2279-2289. doi: https://doi.org/10.1002/ijc.32063
Author information
Authors and Affiliations
Corresponding author
Additional information
Translated from Kletochnye Tekhnologii v Biologii i Meditsine, No. 2, pp. 130-135, June, 2021
Rights and permissions
About this article
Cite this article
Petinati, N.A., Shipounova, I.N., Fastova, E.A. et al. Changes in Bone Marrow Stromal Progenitor Cells in Patients with Hematoblastosis at the Onset of the Disease. Bull Exp Biol Med 171, 553–558 (2021). https://doi.org/10.1007/s10517-021-05268-3
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10517-021-05268-3